182 related articles for article (PubMed ID: 25262178)
21. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.
Tunca Z; Ozerdem A; Ceylan D; Yalçın Y; Can G; Resmi H; Akan P; Ergör G; Aydemir O; Cengisiz C; Kerim D
J Affect Disord; 2014 Sep; 166():193-200. PubMed ID: 25012431
[TBL] [Abstract][Full Text] [Related]
22. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
Eden Evins A; Demopulos C; Nierenberg A; Culhane MA; Eisner L; Sachs G
Bipolar Disord; 2006 Feb; 8(1):75-80. PubMed ID: 16411983
[TBL] [Abstract][Full Text] [Related]
23. Correlation of plasma brain-derived neurotrophic factor and metabolic profiles in drug-naïve patients with bipolar II disorder after a twelve-week pharmacological intervention.
Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang CL; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
Acta Psychiatr Scand; 2015 Feb; 131(2):120-8. PubMed ID: 25131388
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
[TBL] [Abstract][Full Text] [Related]
25. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Buckley PF; Paulsson B; Brecher M
J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
[TBL] [Abstract][Full Text] [Related]
26. Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial.
Arabzadeh S; Ameli N; Zeinoddini A; Rezaei F; Farokhnia M; Mohammadinejad P; Ghaleiha A; Akhondzadeh S
Bipolar Disord; 2015 Sep; 17(6):606-14. PubMed ID: 26291962
[TBL] [Abstract][Full Text] [Related]
27. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
28. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders.
Yoshimura R; Nakano Y; Hori H; Ikenouchi A; Ueda N; Nakamura J
Hum Psychopharmacol; 2006 Oct; 21(7):433-8. PubMed ID: 17029305
[TBL] [Abstract][Full Text] [Related]
29. ALDH2 polymorphism, associated with attenuating negative symptoms in patients with schizophrenia treated with add-on dextromethorphan.
Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
J Psychiatr Res; 2015 Oct; 69():50-6. PubMed ID: 26343594
[TBL] [Abstract][Full Text] [Related]
30. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania.
Delbello MP; Schwiers ML; Rosenberg HL; Strakowski SM
J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1216-23. PubMed ID: 12364843
[TBL] [Abstract][Full Text] [Related]
31. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.
Ketter TA; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S45-53. PubMed ID: 17383011
[TBL] [Abstract][Full Text] [Related]
32. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode.
Machado-Vieira R; Dietrich MO; Leke R; Cereser VH; Zanatto V; Kapczinski F; Souza DO; Portela LV; Gentil V
Biol Psychiatry; 2007 Jan; 61(2):142-4. PubMed ID: 16893527
[TBL] [Abstract][Full Text] [Related]
33. Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania.
McElroy SL; Martens BE; Creech RS; Welge JA; Jefferson L; Guerdjikova AI; Keck PE
J Clin Psychiatry; 2010 May; 71(5):557-65. PubMed ID: 20361901
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
Marcus R; Khan A; Rollin L; Morris B; Timko K; Carson W; Sanchez R
Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
[TBL] [Abstract][Full Text] [Related]
36. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
[TBL] [Abstract][Full Text] [Related]
37. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
[TBL] [Abstract][Full Text] [Related]
38. Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.
Bahk WM; Shin YC; Woo JM; Yoon BH; Lee JS; Jon DI; Chung SK; Choi SK; Paik IH; Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):115-21. PubMed ID: 15610953
[TBL] [Abstract][Full Text] [Related]
39. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.
Friedman SD; Dager SR; Parow A; Hirashima F; Demopulos C; Stoll AL; Lyoo IK; Dunner DL; Renshaw PF
Biol Psychiatry; 2004 Sep; 56(5):340-8. PubMed ID: 15336516
[TBL] [Abstract][Full Text] [Related]
40. [Effectiveness, safety and practicality of delayed-release minitablets of valproate in bipolar affective disorders].
Grunze H; Amann B; Schäfer M; Sterr A; Schaerer L; Wild E; Walden J
Fortschr Neurol Psychiatr; 2000 Nov; 68(11):496-502. PubMed ID: 11144934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
